Momentum towards malaria elimination the Asia Pacific region is unprecedented. With zero cases in Sri Lanka, Malaysia and China, an estimated 50% reduction in India over two years, and extraordinary success in the Mekong, we can see the extent of progress so far. The APLMA-APMEN Secretariat made significant strides in 2018 to expand the fight against Malaria, bringing in new champions, new leadership from the private sector and new energy to APMEN.
Malaria elimination requires collective effort. The partnerships and joint initiatives we launched in 2018 are testament to the passion and commitment of thousands of people across the region. With the London Summit, and the 1st Malaria World Congress in Melbourne, 2018 was in many ways a turning point. In 2019, we will redouble efforts, with a particular focus on the new frontiers of p.vivax malaria, accelerating towards elimination in Indonesia, and turning the tide in Melanesia.
Next week in Bangkok, we look forward to welcoming senior government officials and diverse partners to #MalariaWeek2019. Hosted by the Government of Thailand, malaria week will unite national, regional, and global stakeholders to accelerate efforts towards malaria elimination.
Let me take this opportunity to sincerely thank all our partners. I think I can speak for all of us when I say that from this point onwards, success or failure is very much in our own hands.
Dr. Benjamin Rolfe
CEO, Asia Pacific Leaders Malaria Alliance
This April, the Government of Thailand will host Malaria Week 2019 – a convening of high-level government officials and key partners to work together towards the goal of elimination of malaria from Asia - Pacific by 2030.
Leaders and experts will rally behind the theme “Unite. Accelerate. Eliminate,” calling for strengthened cooperation among stakeholders. A series of meetings will provide a platform for dialogue and information exchange among national, regional, and global stakeholders in the fight against malaria, as well as a crucial opportunity to review progress against the 2030 goal. It will facilitate ‘whole-of-government’ and ‘whole-of-community’ approaches that will be required to end malaria for good.
APLMA and APMEN will facilitate the dialogue to benchmark progress against priorities, coordinate regional actions and jointly identify policy, technical and financing solutions to regional and national malaria challenges. (Read more)
Momentum towards malaria elimination the Asia Pacific region is unprecedented. The APLMA-APMEN Secretariat made significant strides in 2018 to expand the fight against Malaria, bringing in new champions, new leadership from the private sector and new energy to APMEN. This interactive timeline outlines partnerships and joint initiatives we launched in last year. They are a testament to the passion and commitment of thousands of people across the region.
Achieving Universal Health Coverage is one of the key targets of the 2030 Agenda for Sustainable Development, and the focus of World Health Day in 2019. Find out how Asia Pacific’s malaria elimination goal is connected to this global health priority through an opinion editorial by Dr. Benjamin Rolfe urging malaria eliminators to embrace and fund this complex agenda.
The region saw two important meetings to address the burgeoning problem of Substandard and Falsified Medicines. The Mekong leaders rallied behind the regional launch of Medicines We Can Trust Campaign in Asia. In Bangladesh, drug regulators, police officers, customs officers and members of the judiciary were trained on the fight against pharmaceutical crime and products affecting consumer health. These also led to identification of a new #MedsWeCanTrust Champion, Dr. Sivong Sengaloundeth, Deputy Director General, Food and Drug Department, Ministry of Health, Lao PDR. (Read more)
To kick-off Malaria Week 2019, APMEN Annual Meeting (AGM) will provide forum for National Malaria Programs and Partner Institutions to review technical and operational progress and elevate lessons learnt and challenges identified for policy advocacy with senior officials at the APLMA SOM. The Network’s key guiding principles which includes country ownership, responsiveness to the diverse elimination contexts, regional health security against mosquito-borne diseases and South-South collaboration will be promoted.
APMEN is pleased to announce the recent election of Sumitomo Chemical as an APMEN Partner Institution during a Joint APMEN Working Group meeting on 6 September 2018 in Bangkok, Thailand. (Read more)
Pun Hlaing Siloam Hospitals (PHSH) and New Holland Myanmar have launched M2030 awareness and fundraising campaigns supporting malaria elimination in Myanmar. One hundred per cent of funds raised go directly to support malaria programs implemented by Population Services International Myanmar. In addition, M2030 and APLMA have signed on new private sector partners across the region. (Read more)
New Senior Director for APMEN Amita Chebbi officially joined the Network in February 2019. Amita brings more than 20 years of private sector and global public health expertise, with a strong focus on strategy, operations, partnership development and fundraising. The APLMA and APMEN joint Secretariat is also grateful to Dr. Effie Espino for her great leadership over the past two years. (Read more)
Efforts to strengthen medicines regulation and accelerate the registration of tools to test and treat malaria are underway in Cambodia and Vietnam. The two scoping missions were conducted under the Indo Pacific Regulatory Strengthening Program (RSP) in partnership with the Australian Therapeutic Goods Administration (TGA).
Progress towards malaria elimination in the Greater Mekong Subregion and urgent need to stop spreading of drug-resistance discussed at a side-event to the New Delhi preparatory meeting for the Sixth Replenishment of the Global Fund to fight AIDS, Tuberculosis and Malaria, to be held in October 2019. (Read more)
A new medicine, tafenoquine, offers fresh hope in global efforts to combat P. vivax malaria. WHO is forging a critical path to ensure access to and safe use of tafenoquine. This guidance around the use of tafenoquine will be developed in parallel with a review of G6PD point-of-care quantitative tests. (Read more)
On January 16 to 18, Japan hosted the G20 Finance Minister and Central Bank Governors Deputy Meeting in Tokyo. Universal Health Coverage (UHC) and the future of health financing were high on the agenda. Following the Deputy Meeting, ADB, APLMA and Malaria No More Japan jointly visited senior representatives of the Ministries of Finance, Foreign Affairs, and Health, as well as JICA, Professor Keizo Takemi and other partners. The conversation centred on the future of health financing including Blended Finance for Impact – the partnership between APLMA, ADB and the Global Fund; the recently announced Regional Health Fund, deepened collaboration on malaria and UHC, as well as opportunities to support the Global Fund's replenishment efforts. (Read more)